Ranitidine-d6 hydrochloride(Synonyms: 盐酸雷尼替丁 d6 (盐酸盐))

发表于由

上海金畔生物科技有限公司为生命科学和医药研发人员提供生物活性分子抑制剂、激动剂、特异性抑制剂、化合物库、重组蛋白、同位素标记物，专注于信号通路和疾病研究领域。
Ranitidine-d6 hydrochloride (Synonyms: 盐酸雷尼替丁 d6 (盐酸盐))

Ranitidine-d6 hydrochloride 是 Ranitidine hydrochloride 的氘代物。Ranitidine hydrochloride 是一种有效的，选择性的，具有口服活性的组胺 H2 受体 (histamine H2-receptor) 拮抗剂，IC50 为 3.3 μM，可抑制胃液分泌。Ranitidine hydrochloride 还一种是 CYP2C19 和 CYP2C9 的弱抑制剂。

Ranitidine-d6 hydrochloride(Synonyms: 盐酸雷尼替丁 d6 (盐酸盐))

Ranitidine-d6 hydrochloride Chemical Structure

CAS No. : 1185238-09-8

规格 是否有货
1 mg Check price and availability
5 mg Check price and availability
10 mg Check price and availability

* Please select Quantity before adding items.

生物活性

Ranitidine-d6 hydrochloride is the deuterium labeled Ranitidine hydrochloride. Ranitidine hydrochloride is a potent, selective and orally active histamine H2-receptor antagonist with an IC50 of 3.3 μM that inhibits gastric secretion. Ranitidine hydrochloride is a weak inhibitor of CYP2C19 and CYP2C9[1][2].

体外研究
(In Vitro)

Stable heavy isotopes of hydrogen, carbon, and other elements have been incorporated into drug molecules, largely as tracers for quantitation during the drug development process. Deuteration has gained attention because of its potential to affect the pharmacokinetic and metabolic profiles of drugs[1].

Shanghai Jinpan Biotech Co Ltd has not independently confirmed the accuracy of these methods. They are for reference only.
分子量

356.90

Formula

C13H17D6ClN4O3S
CAS 号

1185238-09-8
中文名称

盐酸雷尼替丁 d6 (盐酸盐)
运输条件

Room temperature in continental US; may vary elsewhere.
储存方式

Please store the product under the recommended conditions in the Certificate of Analysis.
参考文献

  • [1]. Russak EM, et al. Impact of Deuterium Substitution on the Pharmacokinetics of Pharmaceuticals. Ann Pharmacother. 2019;53(2):211-216.

    [2]. Herling, A.W., et al., Inhibition of 14C-aminopyrine accumulation in isolated rabbit gastric glands by the H2-receptor antagonist HOE 760 (TZU-0460). Agents Actions, 1987. 20(1-2): p. 35-9.

    [3]. Leucuta, A., et al., A pharmacokinetic interaction study between omeprazole and the H2-receptor antagonist ranitidine. Drug Metabol Drug Interact, 2004. 20(4): p. 273-81.

    [4]. Antonio Francesco Ciccaglione, et al. Pylera® plus ranitidine vs Pylera® plus esomeprazole in first-line treatment of Helicobacter pylori infection: Two pilot studies. Helicobacter. 2019 Oct;24(5):e12606.

所有产品仅用作科学研究或药证申报，我们不为任何个人用途提供产品和服务